Bebetter Med Inc

This study tests whether adding the experimental drug BEBT-908 to standard CHOP chemotherapy works better than CHOP alone for people with previously untreated peripheral T-cell lymphoma (PTCL). The trial first explores different dosing schedules to find the best way to combine th…

This study tests whether adding a new drug called BEBT-209 to standard chemotherapy can shrink tumors and help people with advanced triple-negative breast cancer live longer. About 446 women aged 18 to 75 will be randomly assigned to receive either BEBT-209 plus two chemo drugs o…

This study tests a new medicine called BEBT-701, given as a shot under the skin, for people with mild to moderate high blood pressure and high LDL cholesterol. The goal is to see if it is safe and can help lower both blood pressure and cholesterol. About 340 adults aged 18 to 60 …